SpyGlass Pharma, Inc. SGP
36.95 USD +2.87 (+8.41%)
At closeNov 6, 2026, 4:00 PM EST
36.95 0.00 0.00%
After hours · Nov 6, 4:00 PM ET
33.93 Day range 37.12
17.56 52-week range 36.95
- YTD
- +39.94%
- 1 year
- +39.94%
Financial health
Rating
C2 / 5 overall
- DCF 2
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 4
- P/E 1
- P/B 2
Valuation
P/E -21.1×
FY 2025 5y median -21.1× FY 2025
P/S 0.0×
FY 2025 5y median 0.0× FY 2025
P/B -8.5×
FY 2025 5y median -8.5× FY 2025
P/FCF -25.2×
FY 2025 5y median -25.2× FY 2025
EV/EBITDA -19.0×
FY 2025 5y median -19.0× FY 2025
EV/Sales 0.0×
FY 2025 5y median 0.0× FY 2025
FCF Yield -4.0%
FY 2025 5y median -4.0% FY 2025
Profitability
Gross Margin 0.0%
FY 2025 5y median 0.0% FY 2025
Operating Margin 0.0%
FY 2025 5y median 0.0% FY 2025
Net Margin 0.0%
FY 2025 5y median 0.0% FY 2025
ROE 40.3%
FY 2025 5y median 40.3% FY 2025
ROIC -38.6%
FY 2025 5y median -38.6% FY 2025
ROA -34.4%
FY 2025 5y median -34.4% FY 2025
Growth (YoY)
Revenue 0.0%
FY 2025 FY 2025
Operating Income 0.0%
FY 2025 FY 2025
EPS (diluted) 0.0%
FY 2025 FY 2025
Free Cash Flow 0.0%
FY 2025 FY 2025
Financial Health
Current Ratio 12.7×
FY 2025 5y median 12.7× FY 2025
Quick Ratio 12.7×
FY 2025 5y median 12.7× FY 2025
Debt / Equity -0.0×
FY 2025 5y median -0.0× FY 2025
Net Debt / EBITDA 2.4×
FY 2025 5y median 2.4× FY 2025
Interest Coverage 0.0×
FY 2025 5y median 0.0× FY 2025
Dividends
Dividend Yield 0.0%
FY 2025 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2025 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31